Home › Funds › Kynam Capital Management, LP › GERN

Kynam Capital Management, LP position in GERN

GERON CORP · Health Care

Kynam Capital Management, LP reported holding 6,836,318 shares of GERN (GERON CORP) in its Q2 2026 13F filing — a position valued at US$8.8M, representing 0.48% of its reported portfolio and ranking #24 among its reported holdings. Kynam Capital Management, LP has disclosed GERN holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)6.84M sh
Reported value held$8.75M
Portfolio Weight0.48%
First reportedQ1 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Kynam Capital Management, LP's GERN position evolved

Kynam Capital Management, LP first disclosed a stake in GERN in Q1 2025 at 3,659,526 shares (US$5.8M). The position peaked in Q1 2026 at 6,836,318 shares, worth US$10.2M. Across 6 filings, Kynam Capital Management, LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 6,836,318 shares valued at US$8.8M. Notable position changes include a 98% increase in Q1 2026 (shares fell 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 3.66M $5.82M New
Q2 2025 3.46M $4.87M Reduce
Q3 2025 3.46M $4.74M Hold
Q4 2025 3.46M $4.56M Hold
Q1 2026 6.84M $10.19M Add
Q2 2026 6.84M $8.75M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GERN and 13F data

GERN (GERON CORP) is a Health Care company. 18 other funds we track also report a position in GERN — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$54.8M), Soleus Capital Management, L.P. (US$54.8M), Eversept Partners, LP (US$24.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GERN

All GERN fund holders →

FAQ

How long has Kynam Capital Management, LP held GERN?

Kynam Capital Management, LP has disclosed GERN holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is Kynam Capital Management, LP's current position in GERN?

As of Q2 2026, Kynam Capital Management, LP holds 6.84M shares of GERN (GERON CORP), valued at $8.75M, representing 0.48% of its reported portfolio and ranking #24.

Has Kynam Capital Management, LP been buying or selling GERN?

In the latest 13F filing (Q2 2026), Kynam Capital Management, LP held unchanged its position in GERN. The position peaked in Q1 2026 at 6.84M shares.

Which other funds hold GERN?

Other major institutional holders of GERN include RA CAPITAL MANAGEMENT, L.P., Soleus Capital Management, L.P., Eversept Partners, LP, among 18 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.